D.E. Shaw & Co’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
D.E. Shaw & Co's TNGX Position: Q3 2026 in Review
D.E. Shaw & Co opened a new position in Tango Therapeutics (TNGX) in Q3 2026: 60,382 shares worth $1.51M. The stake represents ﹤0.01% of the portfolio and ranks #3460 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in TNGX as recently as Q4 2025.
D.E. Shaw & Co first reported a position in TNGX in Q2 2022 and has held it in 9 quarters since. The position peaked at $9.09M in Q4 2025. 255 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- D.E. Shaw & Co held 60,382 shares of Tango Therapeutics worth $1.51M as of Q3 2026.
- Tango Therapeutics was a new D.E. Shaw & Co position in Q3 2026.
- Tango Therapeutics made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q3 2026, its #3460 holding.
- D.E. Shaw & Co first reported a position in Tango Therapeutics in Q2 2022 and has held it in 9 quarters since.
- D.E. Shaw & Co's Tango Therapeutics position peaked at $9.09M in Q4 2025.
- 255 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.